Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400091370Phase 4Not yet recruiting
Phase 4, open-label trial of esketamine, lidocaine, sufentanil and remifentanil in airway stenosis (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Time-weighted average SpO2/FiO2 ratio during the initial postoperative hour. Planned start Oct 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400091370.